Diferenças na disponibilidade de medicamentos prescritos na Atenção Primária: evidências do Projeto Prover

Bueno, Maria Angélica; Simões, Taynãna César; Luz, Tatiana Chama Borges

doi:10.1590/1413-81232022273.38782020

Cited by 5 publications

(3 citation statements)

References 43 publications

(60 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This result confirms previous findings in the same municipality showing that the unavailability of medicines in SUS was a recurring issue in the perception of pharmacists and patients 35 . Recently, another study assessed the availability of medicines in the public system and found that only 39.4% of patients had access to all prescribed medicines 3 . The adequate provision of free medicines would reduce OOPPE Prevalence and factors associated with out-of-pocket pharmaceutical expenditure among primary healthcare patients: evidence from the Prover Project and increase access to medicines.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project

Alves¹,

Law

Luz

2022

Value in Health Regional Issues

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…Research carried out in the country has found widespread shortages of medicines at the public community pharmacies. Consequently, access to medicines by patients is substandard [3][4][5][6] leading them to purchase their treatments from the private sector 7 .…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project

Alves¹,

Law

Luz

2022

Value in Health Regional Issues

View full text Add to dashboard Cite

“…Under these aspects, one of the factors that deserves to be highlighted is related to the users' accessibility to their treatment. Thus, access barriers such as PLWHIV commuting to another city to fetch their medications can lead to loss of therapeutic monitoring, as the users are usually responsible for financially paying for their transportation and, in addition, may have their income compromised, particularly for those individuals who work by production or autonomously 6 .…”

Section: Rbfhssmentioning

confidence: 99%

A ausência de unidades dispensadoras de medicamentos em municípios pode influenciar no abandono ao tratamento por pessoas vivendo com HIV/AIDS?

PAULA-FRANÇA,

SANTANA

2023

Rev Bras Farm Hosp Serv Saude

View full text Add to dashboard Cite

Objetivo: verificar a existência de associação entre o abandono à terapia antirretroviral (TARV) por PVHA e a não disponibilização de serviço de dispensação em municípios situados na região Sul do Brasil. Métodos: estudo exploratório e analítico, realizado a partir de registros de Pessoas Vivendo com HIV/AIDS (PVHA) em abandono de TARV residentes na região Sul do Brasil. Incluiu-se o registro de indivíduos que estavam há, pelo menos, cem dias sem retirar medicamentos. Os dados foram coletados por meio do Sistema de Controle Logístico de Medicamentos (SICLOM), Sistema de Monitoramento Clínico das Pessoas Vivendo com HIV/AIDS (SIMC) e Sistema de Controle de Exames Laboratoriais (SISCEL), no período de outubro a novembro de 2022, referentes aos registros de usuários datados entre 1986 a 2022. Resultados: foram checados os registros de 21.861 usuários. A média de abandono foi 814±831,7 dias, com variação entre 101 a 4.276 dias. A maioria das PVHA em TARV residia no Rio Grande do Sul (n=10.951; 50,1%), uma das Unidades da Federação que apresenta maior incidência de AIDS. Com relação às demais características sociodemográficas, revelou-se que a maioria era do sexo masculino (n=12.300; 56,4%), residente no interior (n=15.905; 72,8%), com faixa etária média de idade de 42,1±13,0, raça/cor branca (n=13.053; 59,7%) e com escolaridade de 4 a 7 anos de estudo (n=6.192; 28,3%). O tempo médio de uso da TARV foi de 7,9±2,1 anos, e 49,0% (n=10.718) das PVHA antes do abandono do tratamento estavam com a carga viral indetectável (<50 cópias/mm3). Em paralelo a isso, foi observado que os participantes da pesquisa que moravam em municípios que não possuíam Unidades Dispensadoras de Medicamentos (UDM) (p<0,02) apresentavam 14,9% (IC 14,5 – 15,3) maior chance de abandonar sua terapia quando comparados aos que residiam em cidades que possuíam serviço de dispensação de antirretrovirais. Conclusão: esses achados apontaram que o abandono à TARV por PVHA pode ter uma associação com a distribuição espacial das UDM. Para tanto, descentralizar o acesso aos antirretrovirais é uma estratégia que poderá repercutir positivamente na qualidade de vida e aumentar o tempo de sobrevida dos pacientes da região Sul do Brasil.

show abstract

MedMinas project: design and use of mixed methods in the evaluation of pharmaceutical services in primary health care in Minas Gerais, Brazil

Luz

Tavares

Castro

et al. 2022

BMC Med Res Methodol

Self Cite

View full text Add to dashboard Cite

Background The main purposes of primary care-based pharmaceutical services (PHCPS) in Brazil are to provide free access to medicines and pharmaceutical care to patients. Several obstacles hinder achieving their goals; thus, MedMinas Project aimed to evaluate the PHCPS, the supply system, and the use of medicines. This paper reflects on our experience designing, planning, and conducting the project, describing the issues yielded in the field and lessons learned. Methods This work consists of a mixed-methods study conducted in Minas Gerais, Southeastern Brazil. We adopted the principles of Rapid Evaluation Methods, employing a multistage stratified sampling for the quantitative and a purposeful sampling for the qualitative components, respectively, and a documentary research. Data sources included individuals (patients and professionals), prescriptions, dispensed medicines, and policy documents collected between April and October 2019. The quantitative data described in this paper were analysed by descriptive statistics and the qualitative by Thematic Content Analysis. Results A total of 26 municipalities varying from 37,784 to 409,341 inhabitants were included. The field team spent, on average, 16 days in each location. We interviewed 1019 respondents, of which 127 were professionals and 892 patients. The participation rate varied from 92 to 100%, depending on the respondent subgroup. Most interviews lasted between 45 min and one hour. Fieldwork challenges included participants’ enrolment, field team, interview processes, and project budget. The participants provided positive feedback and five main themes emerged from the interview experience (self-awareness, sense of gratitude, research value, access to findings, and benefits of the research). Additionally, we collected copies of 1072 documents and 2070 pieces of data from prescriptions filled and medicines dispensed at the PCP. Conclusion We demonstrated the viability of conducting the MedMinas Project in an extensive geographic area within effective time frames that provided meaningful, high-quality data from multiple actors. The methods and lessons learned are valuable for researchers across various disciplines in similar urban settings in Brazil and other countries of low- and middle-income (LMIC).

show abstract

Diferenças na disponibilidade de medicamentos prescritos na Atenção Primária: evidências do Projeto Prover

Cited by 5 publications

References 43 publications

Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project

Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project

A ausência de unidades dispensadoras de medicamentos em municípios pode influenciar no abandono ao tratamento por pessoas vivendo com HIV/AIDS?

MedMinas project: design and use of mixed methods in the evaluation of pharmaceutical services in primary health care in Minas Gerais, Brazil

Contact Info

Product

Resources

About